BunyaVax
BunyaVax exploits proprietary vaccine platform technology to develop safe and efficacious vaccines against infectious diseases and cancer.
BunyaVax operates in biotechnology, health care based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.
BunyaVax is positioned in biotechnology, health care, a segment that rewards a clear, focused offering.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Directory data places it at the Grant stage.
Its team size is recorded as c_00001_00010 employees.
Total disclosed funding stands at about $71K.
| Sector | Biotechnology, Health Care |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $71,429 |
Website: www.bunyavax.com
Sign in to view the contact information we hold for BunyaVax.
Create a free account
Create a free account